Wed, June 7, 2023

David Macdonald Downgraded (AMED) to Hold and Held Target at $97 on, Jun 7th, 2023

David Macdonald of Truist Securities, Downgraded "Amedisys, Inc." (AMED) to Hold and Held Target at $97 on, Jun 7th, 2023.

David has made no other calls on AMED in the last 4 months.



There are 8 other peers that have a rating on AMED. Out of the 8 peers that are also analyzing AMED, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $100 on, Tuesday, June 6th, 2023
  • Sarah James of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $100 on, Tuesday, June 6th, 2023
  • Gary Taylor of "TD Cowen" Maintained at Hold with Decreased Target to $84 on, Monday, May 8th, 2023
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $88 on, Friday, May 5th, 2023
  • Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $103 on, Thursday, May 4th, 2023


These are the ratings of the 3 analyists that currently disagree with David


  • Bill Sutherland of "Benchmark" Reiterated at Strong Buy and Held Target at $115 on, Tuesday, June 6th, 2023
  • Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $111 on, Tuesday, February 21st, 2023
  • Mark Miller of "Benchmark" Maintained at Strong Buy with Decreased Target to $115 on, Thursday, February 16th, 2023